• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Harsh R. Shah, DO

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
23 4.7 out of 5 Patient Rating

Languages Spoken: English

Languages Spoken: English, Hindi, Gujarati

Harsh Shah DO is an Assistant Professor of Medicine in the Division of Hematology at the Huntsman Cancer Center, University of Utah.

Dr. Shah’s clinical expertise is in treatment of various lymphomas, such as Hodgkin’s Lymphoma, T-cell Lymphomas, DLBCL, Mantle Cell Lymphoma, Follicular Lymphoma, CLL, etc. He has a research interest in immunotherapy resistance pathways in treatment of Hodgkin Lymphomas, particularly the role of Tumor Associated Macrophages. He is also interested in outcomes research and novel educational strategies for medical students, residents, and fellows.

He completed his internal medicine training at Indiana University in Indianapolis and hematology and oncology fellowship at Karmanos Cancer Institute/Wayne State University in Detroit, Michigan. He is certified in both hematology and oncology.

Specialties

  • Chronic Lymphocytic Leukemia
  • Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma

Board Certification and Academic Information

Academic Departments Internal Medicine - Assistant Professor (Clinical)
Academic Divisions Hematology/BMT

Patient Rating

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Learn About Our Survey

Likelihood of recommending care provider

4.7/ 5

Care provider's explanation of condition/problem

4.7/ 5

Care provider's effort to include me in decisions

4.7/ 5

Wait time at clinic

4.4/ 5

Care provider's concern for questions & worries

4.7/ 5

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

UofU Patient March 01, 2022
HUNTSMAN CANCER CENTER

5 out of 5 stars

I was impressed by the time and care I received.

UofU Patient December 06, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr Shah is thoroughly familiar with the process and subject matter. Explained everything in great detail, listened with utmost care, taking copious notes. My wife and I feel we are in the most capable hands.

UofU Patient November 22, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

The N/P wes very thorough in explaining my diagnosis, and ensuring discussion, she was great

UofU Patient November 21, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

The physician was very helpful and took the time to first explain and then offer information and answered all my questions. He helped my to be able to ask questions.

UofU Patient November 16, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Good

UofU Patient November 02, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

It shows when people like working at any place, and I've noticed that doctors, nurses and staff in general like working at Huntsman. Always a high degree of professionalism, from the doctors to the cafeteria staff. Dr Shah is always very kind and feels like he knows what he's doing. Highly skilled doctor. All his PAs are always very kind and thoughtful. Always a good experience.

UofU Patient September 10, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

I am kept informed of my health

UofU Patient September 06, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

We really like Dr Shah. Thanks!

UofU Patient September 03, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Awesome Doctors. Love my Doctors here and study coordinator. Everyone is excellent at their job

UofU Patient August 27, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

So far I have been pleased with all aspects of my treatment

UofU Patient August 08, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr. Shah is great. His care and concern are exemplary.

UofU Patient August 06, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr. Shah has settled in and was awesome during my recent appointment. I was spoiled by Dr. Glen and was expecting a smoother transition.

UofU Patient July 30, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Both Dr. Shah and the PA were very responsive to my questions and concerns. I left feeling very good about the plans we made moving forward.

UofU Patient July 24, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Very satisfied so far

UofU Patient July 20, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

My doctor was awesome

UofU Patient June 27, 2021
HUNTSMAN CANCER CENTER

4 out of 5 stars

The ratings in this section would have all been very good if I had taken it upon myself to ask more questions

UofU Patient June 19, 2021
HUNTSMAN CANCER CENTER

3 out of 5 stars

good

UofU Patient June 18, 2021
HUNTSMAN CANCER CENTER

4 out of 5 stars

I was giving bad news on blood test results will no directional guidance where to go next.

UofU Patient June 14, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

After Dr. Martha Glen's retirement, I was concerned about her replacement. Dr. Shah was exceptionally through and helpful. No one can replace Dr. Glen's "bedside" manner, but Dr. Shah was a pleasant surprise.

UofU Patient May 23, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Jessica Coon is amazing, always.Great to meet Dr. Shah. very impressive.

UofU Patient May 08, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

She was wonderful!!

UofU Patient May 07, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Explained pros and cons of doing a biopsy of two apparent enlarged lymph nodes.

UofU Patient May 07, 2021
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr. Shah is the best. The staff he has assembled are also great.

Languages Spoken: English, Hindi, Gujarati

Harsh Shah DO is an Assistant Professor of Medicine in the Division of Hematology at the Huntsman Cancer Center, University of Utah.

Dr. Shah’s clinical expertise is in treatment of various lymphomas, such as Hodgkin’s Lymphoma, T-cell Lymphomas, DLBCL, Mantle Cell Lymphoma, Follicular Lymphoma, CLL, etc. He has a research interest in immunotherapy resistance pathways in treatment of Hodgkin Lymphomas, particularly the role of Tumor Associated Macrophages. He is also interested in outcomes research and novel educational strategies for medical students, residents, and fellows.

He completed his internal medicine training at Indiana University in Indianapolis and hematology and oncology fellowship at Karmanos Cancer Institute/Wayne State University in Detroit, Michigan. He is certified in both hematology and oncology.

Academic Locations

Board Certification and Academic Information

Academic Departments Internal Medicine - Assistant Professor (Clinical)
Academic Divisions Hematology/BMT

Education History

Fellowship Karmanos Cancer Institute-Wayne State University
Hematology-Oncology
Fellow, 2019
Residency Indiana University School of Medicine
Internal Medicine
Resident, 2016
Professional Medical Kirksville College of Osteopathic Medicine, AT Still University of Health Sciences
Osteopathic Medicine
D.O., 2013
Graduate Training University of Michigan
Biomedical Engineering
M.S.E., 2009
Undergraduate University of Michigan
Biomedical Engineering
B.S.E., 2008

Selected Publications - Journal Articles

Journal Article

  1. Harsh Shah, Seongho Kim, Scott Klimecki, Karl Charlson, Joseph Uberti, Charles A Schiffer, Mark A Fiala Erlene Seymour (2022). Racial disparities in time to hematopoietic cell transplant among patient with hematologic malignancies at a large urban academic center. Bone Marrow Transplantation. Supplement.
  2. Shah HR, Stephens DM (2021). Is there a role for anti-CD20 antibodies in CLL? Hematology Am Soc Hematol Educ Program, 2021(1), 68-75.
  3. Harsh Shah, Hyejeong Jang, Paramveer Singh, Jorgena Kosti, Andrew Kin, Asif Alavi, Voravit Ratanatharathorn, Lois Ayash, Joseph Uberti, Radhakrishnan Ramchandren, Seongho Kim, Abhinav Deol (11/15/2021). Improved post-ASCT survival of relapsed/refractory classical Hodgkin lymphoma patients in the era of novel agents.
  4. Isabella Frances McNamara, Scott Rizzi, Bryan Still, Harsh Shah (2021). An unusual cause of encephalopathy in the setting of a new diagnosis of DLBCL. 7.
  5. Orellana-Noia VM, Reed D, McCook AA, Sen JM, Barlow CM, Malecek MK, Watkins MP, Kahl BS, Spinner MA, Advani R, Voorhees TJ, Snow A, Grover NS, Ayers AA, Romancik J, Liu Y, Huntington SF, Chavez JC, Saeed H, Lazaryan A, Raghunathan V, Spurgeon SE, Ollila TA, Del Prete C, Olszewski A, Ayers EC, Landsburg DJ, Echalier B, Lee J, Kamdar M, Caimi PF, Fu T, Liu J, David KA, Alharthy H, Law JY, Karmali R, Shah HR, Stephens DM, Major A, Rojek AE, Smith SM, Yellala A, Kallam A, Nakhoda S, Khan N, Sohail MA, Hill BT, Barrett-Campbell O, Lansigan F, Switchenko JM, Cohen JB, Portell CA (2021). Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions. Blood, 139, 413-423.
  6. Shah HR, Stephens DM, Seymout J, Maddocks K (2021). Incorporating Novel Targeted and Immunotherapeutic Agents in the Treatment of B-Cell Lymphomas. Am Soc Clin Oncol Educ Book, 41, 310-327.
  7. Harsh Shah, Deborah Stephens, John Seymour, Kami Maddocks (03/25/2021). Incorporating Novel Targeted and Immunotherapeutic Agents in Treatment of B-Cell Lymphomas.
  8. Vaishampayan U, Shah HR, Asad MF, Shi D, Brenda D, Stacey S, Jason D, Cher ML, Samantray J, Aoun HD (2020). Adrenal Metastases as Sanctuary Sites in Advanced Renal Cancer. 7(4).
  9. Shah HR, Kim S, Singh P, Alavi A, Ratanatharathom V, Ayash L, Uberti J, Deol A (2019). Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G-CSF or G-CSF and plerixafor mobilizes grafts. Am J Hematol.
  10. Shah H, Vaishampayan U (2018). Therapy of Advanced Prostate Cancer: Targeting the Androgen Receptor Axis in Earlier Lines of Treatment. Target Oncol, 13(6), 679-689.
  11. Shah H, Bradford C, Sayar H (2015). Acute Promyelocytic Leukemia Presenting with Severe Marrow Fibrosis. Case Rep Hematol, 2015, 826894.

Case Report

  1. Shah H, McPherson K, Mansour A, Ramirez-Santrich C, Nassiri M, Shahda S (2016). Neuroendocrine Differentiation of a Primary BRAF Mutant Colon Cancer in a Patient With a History of Hairy Cell Leukemia. Clin Colorectal Cancer, 15(4), e235-e239.

Abstract

  1. Shah H, et al (2015). Quality of Life Survey in Nonmyeloablative Bone Marrow Transplant Patients at a Large Academic Center [Abstract]. Blood, 126(56), 12.

Site Links

  • Find an Interpreter
  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • Referring Providers

Helpful Links

  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Surprise Billing Rights
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

801-581-2121

  • Facebook
  • Twitter
  • Youtube
  • Instagram

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2022 University of Utah Health